HLB Co., Ltd.
028300
Rang in aandelen
#3920
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Aandeelprijs
$31.27
Marktkapitalisatie
$4.16B
Verandering (1 dag)
6.78%
Verandering (1 jaar)
1.26%
Land
KR
Handel HLB Co., Ltd. (028300)
Categorie
Healthcare
Koersgeschiedenis voor HLB Co., Ltd. (028300)
Hoogste slotkoers: $29.89 op 2026-10-01
Laagste slotkoers: $1.36 op 2008-12-01
Laagste slotkoers: $1.36 op 2008-12-01
Koersgeschiedenis van HLB Co., Ltd. van 2008 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 0.63% |
| 2025 | -33.96% |
| 2024 | 57.41% |
| 2023 | 40.26% |
| 2022 | -17.38% |
| 2021 | -30.97% |
| 2020 | 8.36% |
| 2019 | 23.72% |
| 2018 | 110.61% |
| 2017 | 199.59% |
| 2016 | -34.89% |
| 2015 | 161.99% |
| 2014 | 189.01% |
| 2013 | -5.55% |
| 2012 | 30.30% |
| 2011 | 0.39% |
| 2010 | -50.22% |
| 2009 | 13.14% |
| 2008 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
